Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

UCHL1 inhibits BASP1. 1 / 1

| 1

➶

reach

"Therefore, the neuroprotective effect of 3α-DIOL against PAC-induced painful neuropathological symptoms appears to be dependent on its ability to reverse to normal values decreased NF expression level, reduced CV and NAP peak amplitude in PAC-treated rat peripheral nerves.Moreover, our results also revealed that 3α-DIOL modulate differentially the expression of CNPase, NF200 and PGP9.5 genes."

24260511

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...